$87,500
median · per year, annualized USD
$123,300
median · per year, annualized USD
Sales Development Representative - Medical Equipment
Respiratory Pharmaceutical Sales Representative - Bel-Air, MD
Respiratory Pharmaceutical Sales Representative – Dayton, OH (North)
Respiratory Pharmaceutical Sales Representative – Beckley, West Virginia
Pharmaceutical Sales Representative - NY/NY
Pharmaceutical Sales Representative - Edison, NJ
Respiratory Pharmaceutical Sales Representative – Cincinnati, OH (West)
Pharmaceutical Sales Representative - NY/NY
Pharmaceutical Field Sales Representative
Pharmaceutical Sales Representative - GI - St. Louis, MO
Associate Director, Drug Safety
Drug Safety Associate III
Drug Safety Associate II
Senior Specialist I, Patient Safety & Pharmacovigilance (Clinical Trial Safety Operations)
Associate Specialist Drug Safety
Specialist I, Patient Safety and Pharmacovigilance Operations
| Company | Median | Roles |
|---|---|---|
Inizio Engage
|
$80,000 | 47 |
Skilled Wound Care
|
$73,000 | 11 |
Amplity Health
|
$87,500 | 8 |
GSK
|
$156,000 | 7 |
| ME Medline | $122,500 | 6 |
Danaher
|
$95,000 | 2 |
CHG Healthcare
|
$60,000 | 2 |
Cardinal Health
|
$49,920 | 2 |
| Company | Median | Roles |
|---|---|---|
Exelixis
|
$142,000 | 2 |
Corcept Therapeutics
|
$98,375 | 2 |
Iambic Therapeutics, Inc
|
$184,500 | 1 |
MSD
|
$92,550 | 1 |
| Location | Median | Roles |
|---|---|---|
| Chicago | $80,000 | 3 |
| Los Angeles | $77,000 | 4 |
The median for Pharmaceutical Sales is $87,500 per year (typically $75,500–$128,750), versus $123,300 for Pharmacovigilance ($99,500–$149,875). That puts Pharmacovigilance about 41% ahead at the median.
Both figures are computed live from active listings on JobsRadar and normalized to annualized USD, so Pharmaceutical Sales and Pharmacovigilance are compared on equal terms regardless of the currency each role was originally posted in. Only roles that publish a salary range feed the medians; numbers refresh every few hours as new roles post and older ones close, so this comparison reflects the market right now rather than a fixed survey. Use it as a directional benchmark when weighing one path against the other.